Literature DB >> 32469251

The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?

Giovanni Grandi1, Fabio Facchinetti1, Johannes Bitzer2.   

Abstract

Objective: Although sex-disaggregated data for COVID-19 show equal numbers of cases between men and women, there seem to be sex differences in mortality rate and vulnerability to the disease: more men than women are dying.
Methods: We have explored the potential role of estrogens in this COVID-19 gendered impact.
Results: Estrogens stimulate the humoral response to viral infections, while testosterone and progesterone give an immune suppression of both innate and cell-mediated immune responses. We hypothesise that estrogens, in particular estradiol but also synthetic estrogen such as ethinylestradiol, could protect women from the most serious complications of COVID-19. The use of medications that keep hormonal levels high and stable, such as combined hormonal contraceptive, could therefore play a protective role. These potential benefits overtake the thrombotic risk in healthy women. As stated by the World Health Organization, all modern methods of contraception were safe to use during the COVID-19 pandemic.

Entities:  

Keywords:  Androgen; COVID-19; combined hormonal contraception; estradiol; estrogen; postmenopausal hormone therapy; progesterone; testosterone

Mesh:

Substances:

Year:  2020        PMID: 32469251     DOI: 10.1080/13625187.2020.1766017

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  19 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Sex-derived attributes contributing to SARS-CoV-2 mortality.

Authors:  Neha Chanana; Tsering Palmo; Kavita Sharma; Rahul Kumar; Brian B Graham; Qadar Pasha
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-07-29       Impact factor: 4.310

Review 3.  The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives.

Authors:  Stavroula Pegiou; Elpiniki Rentzeperi; Theocharis Koufakis; Symeon Metallidis; Kalliopi Kotsa
Journal:  Microbes Infect       Date:  2021-06-12       Impact factor: 2.700

Review 4.  The role of estradiol in the immune response against COVID-19.

Authors:  Adrián Ramírez-de-Arellano; Jorge Gutiérrez-Franco; Erick Sierra-Diaz; Ana Laura Pereira-Suárez
Journal:  Hormones (Athens)       Date:  2021-06-17       Impact factor: 2.885

Review 5.  The Many Faces of Innate Immunity in SARS-CoV-2 Infection.

Authors:  Nicholas Hanan; Ronnie L Doud; In-Woo Park; Harlan P Jones; Stephen O Mathew
Journal:  Vaccines (Basel)       Date:  2021-06-04

Review 6.  An overview of sex hormones in relation to SARS-CoV-2 infection.

Authors:  Marzieh Saei Ghare Naz; Mojdeh Banaei; Sareh Dashti; Fahimeh Ramezani Tehrani
Journal:  Future Virol       Date:  2021-07-20       Impact factor: 1.831

7.  Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.

Authors:  Yen-Hung Wu; I-Jeng Yeh; Nam Nhut Phan; Meng-Chi Yen; Jui-Hsiang Hung; Chung-Chieh Chiao; Chien-Fu Chen; Zhengda Sun; Hui-Ping Hsu; Chih-Yang Wang; Ming-Derg Lai
Journal:  J Microbiol Immunol Infect       Date:  2021-03-26       Impact factor: 4.399

8.  Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.

Authors:  Angela Toss; Matteo Lambertini; Kevin Punie; Giovanni Grandi; Laura Cortesi
Journal:  Int J Cancer       Date:  2020-07-01       Impact factor: 7.316

9.  Sex and age differences in COVID-19 mortality in Europe&nbsp.

Authors:  Linda Juel Ahrenfeldt; Martina Otavova; Kaare Christensen; Rune Lindahl-Jacobsen
Journal:  Res Sq       Date:  2020-08-19

10.  Repurposing existing drugs for COVID-19: an endocrinology perspective.

Authors:  Flavio A Cadegiani
Journal:  BMC Endocr Disord       Date:  2020-09-29       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.